Cerianna

Product manufactured by Zionexa Us Corporation

Application Nr Approved Date Route Status External Links
NDA212155 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cerianna Is Indicated For Use With Positron Emission Tomography (Pet Imaging) For Characterization Of Estrogen Receptor (Er) Status Of Known Or Suspected Metastatic Lesions In Patients With Confirmed Er-Positive Breast Cancer. Limitations Of Use Tissue Biopsy Should Be Used To Confirm Recurrence Of Breast Cancer And To Verify Er Status By Pathology. Cerianna Is Not Useful For Imaigng Other Receptors, Such As Human Epidermal Growth Factor Receptor 2 (Her2) And The Progesterone Receptor (Pr) Cerianna Is A Radioactive Diagnostic Agent Indicated For Positron Emission Tomography (Pet) Imaging. Fluoroestradiol F 18 Is Indicated For Characterization Of Estrogen Receptor Status Of Known Or Suspected Metastatic Lesions In Patients With Confirmed Er-Positive Breast Cancer.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fluoroestradiol F-18

Comments